Entering text into the input field will update the search result below

ResMed EPS in-line, beats on revenue

Jul. 28, 2016 4:10 PM ETResMed Inc. (RMD) StockBy: SA News Team
  • ResMed (NYSE:RMD): FQ4 EPS of $0.74 in-line.
  • Revenue of $518.65M (+14.5% Y/Y) beats by $4.68M.
  • Press Release

Recommended For You

More Trending News

About RMD Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RMD--
ResMed Inc.